C4X Discovery Taxonomy3
c4xdiscovery.com
Spec sheet
- Headquarters
- Leeds, United KingdomRead 21 Oct 2026 · c4xdiscovery.com
- Clinical-trial application
- PatientSeek is described as supporting clinical-trial design and companion diagnostics.Read 14 Nov 2026 · c4xdiscovery.com
- Collaboration
- C4X Discovery describes a Taxonomy3 collaboration with the GEN-COVID Consortium in Italy to examine COVID-19 genetics.Read 14 Nov 2026 · c4xdiscovery.com
- Commercial model
- C4X Discovery says its business model includes pre-clinical licensing deals with pharmaceutical companies.Read 14 Nov 2026 · c4xdiscovery.com
- Drug discovery use
- The company says Taxonomy3-derived targets can inform drug discovery and biomarker identification.Read 14 Nov 2026 · c4xdiscovery.com
- Genetic analysis
- Taxonomy3 uses mathematical analysis of genetic data to identify disease-causing targets.Read 14 Nov 2026 · c4xdiscovery.com
- Omics inputs
- PatientSeek uses genetics and other omics analyses to stratify patients.Read 14 Nov 2026 · c4xdiscovery.com
- Partnership contact
- The company invites inquiries about strategic collaboration and technology partnership opportunities.Read 14 Nov 2026 · c4xdiscovery.com
- Patient stratification
- PatientSeek is a patient-stratification platform powered by Taxonomy3.Read 14 Nov 2026 · c4xdiscovery.com
- Product positioning
- C4X Discovery describes itself as a drug discovery company focused on small-molecule medicines for immuno-inflammatory diseases.Read 14 Nov 2026 · c4xdiscovery.com
- Registered office
- C4X Discovery lists its registered office in Leeds, United Kingdom.Read 14 Nov 2026 · c4xdiscovery.com
- Taxonomy3 platform
- Taxonomy3 is a target-identification platform based on human genetics.Read 14 Nov 2026 · c4xdiscovery.com
Where Specifiction places it
- AI Drug Discovery Software#11 of 336.6